Healthcare
LSP-HEF co-leads Curetis's series-B extension
Molecular diagnostics company has raised €63.5m since inception
Vesalius et al. invest €20m in Promethera
Company recently completed phase-I/II trials of its HepaStem product
HTGF backs PS Biotech
HTGF has backed industrial biotech provider since its spinout in 2013
Imperial et al. invest £50m in Cell Medica
Brings total amount raised by company to ТЃ72.5m
Gimv et al. exit listed Prosensa
Sale resulted in 4.6x return on historial investment cost for Gimv
Finnish Industry Investment in €2.3m round for NewIcon
Fresh capital for product development and international expansion
Thuja, Index invest €5.5m in Encare
Company span out from University Medical Centre Utrecht earlier this year
New Wave et al. invest in Endomagnetics
Funding will be used to support the company's US clinical trial
Theranexus raises €3.6m
Company will use funds to start its first clinical programme
LBO France buys Fournitures Hospitalières
GP carried out the deal via €154m small-cap Hexagone III fund
Adelis buys Med Group from Terveysrahasto
Founders and management will retain minority stake following buyout
Capricorn et al. raise €15m in Nexstim float
Company has received тЌ25.1m in capital since 2007
NEA et al. invest $33.1m in Ziarco
Existing backers Pfizer Ventures & BVF also took part
Parter Capital injects CHF 4.5m into Histide
Private equity house specialises in research-based investments
Seventure et al. back Humedics' series-C
Company's existing investors also committed to the round
Waterland sells Omega for €3.6bn
Deal values Omega's equity at €2.48bn
EQT buys Siemens Audiology Solutions for €2.15bn
Private equity group intends to list the company
Molecular floats with CHF 482m market cap
Shares dropped to CHF 22.4 within hours, having opened on CHF 25
Bayer commits $25m to Versant's fifth fund
Bayer and Versant had already worked together on drug discovery incubator
Molecular Partners to raise CHF 96m after IPO delay
Offering will give company a market cap of CHF 485m
Sunstone et al. sell Galecto for $444m
Bristol-Myers Squibb signs option to buy company within 60 days of successful clinical trials
Seventure et al. invest £27m in Quanta
Round led by Air Liquide's venture capital arm, Aliad
Venture-backed F-Star acquired by Bristol-Myers Squibb
Bristol has acquired Viennese company F-Star Alpha for up to $475m
Probiodrug raises €22.5m in Euronext IPO
Fresh capital to be used for advancing development of Alzheimer's drug